Rocephin (Ceftriaxone) Dosing and Administration
Adult Dosing
For most adult infections, administer ceftriaxone 1–2 grams IV once daily or in divided doses twice daily, with a maximum of 4 grams per day. 1
Standard Adult Regimens by Indication
Community-acquired pneumonia and general infections: 1–2 g IV once daily 1
- Recent evidence suggests 1 g daily achieves similar mortality outcomes to 2 g daily for CAP in regions with low penicillin-resistant Streptococcus pneumoniae, with lower C. difficile rates and shorter hospital stays 2
- However, for sepsis presenting to the emergency department, 2 g once daily is preferred to ensure therapeutic exposure in >90% of patients with creatinine clearance ≤140 mL/min 3
Bacterial meningitis: 2 g IV every 12 hours (or 4 g once daily), combined with vancomycin to cover resistant Streptococcus pneumoniae 4
- Add ampicillin 2 g every 4 hours for patients >50 years or with risk factors for Listeria monocytogenes (immunosuppression, diabetes, cancer) 4
- High-dose regimens (75–100 mg/kg/day, up to 7 g/day) are well-tolerated in CNS infections, though caution is warranted in elderly patients or those with renal impairment 5
Uncomplicated gonorrhea: Single IM dose of 250 mg 1
Surgical prophylaxis: 1 g IV administered 0.5–2 hours before incision 1
No renal or hepatic dose adjustment is required unless severe impairment is present 1
Pediatric Dosing
For children beyond the neonatal period, administer 50–75 mg/kg/day for most infections, with a maximum daily dose of 2 grams; for meningitis, use 100 mg/kg/day (maximum 4 grams daily). 1
Pediatric Regimens by Indication
Skin and soft tissue infections: 50–75 mg/kg once daily or divided twice daily (maximum 2 g/day) 1
Acute otitis media: Single IM dose of 50 mg/kg (maximum 1 g) 1
Serious infections (excluding meningitis): 50–75 mg/kg/day divided every 12 hours (maximum 2 g/day) 1
Bacterial meningitis:
- Initial dose: 100 mg/kg IV (maximum 4 g) 1
- Maintenance: 100 mg/kg/day once daily or divided every 12 hours (maximum 4 g/day) for 7–14 days 1
- Combine with vancomycin 10–15 mg/kg every 6 hours (target trough 15–20 mg/mL) 4
- Recent pharmacokinetic modeling suggests once-daily dosing (100 mg/kg) achieves superior CSF target attainment earlier than twice-daily dosing (50 mg/kg) for empirical meningitis treatment 6
- For critically ill children, the standard 100 mg/kg once-daily dose provides adequate exposure for susceptible pathogens (MIC ≤0.5 mg/L), but consider 50 mg/kg twice daily in patients with creatinine clearance >80 mL/min/1.73 m² or when treating less-susceptible organisms 7
Neonatal Dosing and Critical Contraindications
Ceftriaxone is contraindicated in premature neonates and in term neonates (≤28 days) receiving or expected to receive IV calcium-containing solutions, including parenteral nutrition. 1
Neonatal-Specific Warnings
Hyperbilirubinemic neonates, especially premature infants, should not receive ceftriaxone due to risk of bilirubin encephalopathy 1
IV administration in neonates must be infused over 60 minutes (not 30 minutes as in older patients) to reduce bilirubin displacement risk 1
For neonates <1 month requiring empirical meningitis coverage, use ampicillin plus cefotaxime or an aminoglycoside instead of ceftriaxone 4
Administration and Compatibility
IV Administration
Infuse over 30 minutes in children and adults; 60 minutes in neonates 1
Reconstitute vials with appropriate IV diluent to achieve concentrations of 10–40 mg/mL (lower concentrations acceptable if needed) 1
Never use calcium-containing diluents (Ringer's solution, Hartmann's solution) for reconstitution or dilution, as ceftriaxone-calcium precipitation can occur 1
Do not administer simultaneously with calcium-containing IV solutions via Y-site in any patient 1
- In patients >28 days old, ceftriaxone and calcium solutions may be given sequentially if lines are thoroughly flushed with compatible fluid between infusions 1
IM Administration
Inject deep into large muscle mass with aspiration to avoid intravascular injection 1
Reconstitute to 250 mg/mL or 350 mg/mL concentration depending on vial size and diluent volume 1
Duration of Therapy
Continue for at least 2 days after clinical improvement for most infections 1
Typical duration: 4–14 days; complicated infections may require longer courses 1
Streptococcal infections (including pharyngitis): Minimum 10 days to prevent acute rheumatic fever 1
Meningitis: 7–14 days 1
Drug Incompatibilities
Do not physically mix or piggyback ceftriaxone with vancomycin, aminoglycosides, amsacrine, or fluconazole. 1
Administer these agents sequentially with thorough line flushing using compatible fluids between infusions 1
Ceftriaxone is compatible with metronidazole (Flagyl IV) at concentrations ≤5–7.5 mg/mL metronidazole with 10 mg/mL ceftriaxone in 0.9% NaCl or D5W, stable for 24 hours at room temperature only (do not refrigerate) 1
Special Monitoring Considerations
Elderly patients and those with renal impairment receiving high-dose ceftriaxone (≥75 mg/kg/day) for CNS infections may benefit from therapeutic drug monitoring, as these populations show increased risk of neurological adverse effects 5
Blood culture collection: When feasible in prehospital or emergency settings, draw cultures before antibiotic administration; contamination rates remain acceptably low (2.5%) even with field collection 8
Adjunctive dexamethasone should be initiated with or up to 4 hours after the first antibiotic dose in suspected bacterial meningitis, but discontinue if Listeria is identified (associated with increased mortality in neurolisteriosis) 4